Cargando…

The number of CD34+CD38+CD117+HLA-DR+CD13+CD33+ cells indicates post-chemotherapy hematopoietic recovery in patients with acute myeloid leukemia

Hematopoietic recovery is considered to be associated with the number of multipotent hematopoietic stem cells in the bone marrow, as observed in functional assays involving stem cell transplantation. However, there is little evidence related to hematopoietic recovery in non-transplantation settings,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Runxia, Wei, Hui, Wang, Ying, Lin, Dong, Liu, Bingcheng, Zhou, Chunlin, Liu, Kaiqi, Gong, Benfa, Wei, Shuning, Zhang, Guangji, Gong, Xiaoyuan, Liu, Yuntao, Li, Yan, Zhao, Xingli, Qiu, Shaowei, Wang, Huijun, Wang, Min, Mi, Yingchang, Wang, Jianxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498054/ https://www.ncbi.nlm.nih.gov/pubmed/28678809 http://dx.doi.org/10.1371/journal.pone.0180624

Ejemplares similares

Distinct genetic alteration profiles of acute myeloid leukemia between Caucasian and Eastern Asian population
por: Wei, Hui, et al.
Publicado: (2018)

Candidemia in Patients with Acute Leukemia: Analysis of 7 Years’ Experience at a Single Center in China
por: Gong, Xiaoyuan, et al.
Publicado: (2020)

Benefit of intermediate-dose cytarabine-containing induction in molecular subgroups of acute myeloid leukemia
por: Wei, Hui, et al.
Publicado: (2020)

Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
por: Gu, Runxia, et al.
Publicado: (2020)

An analysis of 97 previously diagnosed de novo adult acute erythroid leukemia patients following the 2016 revision to World Health Organization classification
por: Qiu, Shaowei, et al.
Publicado: (2017)

The impact of venetoclax based regimens in the preemptive of measurable residual disease in acute myeloid leukemia
por: Fang, Qiuyun, et al.
Publicado: (2022)

Efficacy of combination of venetoclax with azacitidine or chemotherapy in refractory/relapse acute leukemias of ambiguous lineage, not otherwise specified
por: Liu, Kaiqi, et al.
Publicado: (2021)

Gene Deletions and Prognostic Values in B-Linage Acute Lymphoblastic Leukemia
por: Fang, Qiuyun, et al.
Publicado: (2021)

Reduced ABO blood group antibody titers in patients after CD19 CAR-T cell therapy
por: Li, Qiang, et al.
Publicado: (2022)

Expression of CD81 and CD117 in plasma cell myeloma and the relationship to prognosis
por: Chen, Fang, et al.
Publicado: (2018)

Chimeric antigen receptor-modified T-cell therapy for bone marrow and skin relapse Philadelphia chromosome-like acute lymphoblastic leukemia: A case report
por: Yang, Mianzeng, et al.
Publicado: (2020)

Frequencies of CD33+CD11b+HLA-DR–CD14–CD66b+ and CD33+CD11b+HLA-DR–CD14+CD66b– Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19
por: Alberca, Ricardo Wesley, et al.
Publicado: (2020)

Repression of phagocytosis by human CD33 is not conserved with mouse CD33
por: Bhattacherjee, Abhishek, et al.
Publicado: (2019)

The diagnostic power of CD117, CD13, CD56, CD64, and MPO in rapid screening acute promyelocytic leukemia
por: Tran, Vinh Thanh, et al.
Publicado: (2020)

High-Dose Cytarabine in Acute Myeloid Leukemia Treatment: A Systematic Review and Meta-Analysis
por: Li, Wei, et al.
Publicado: (2014)

Hyperfunction of CD4 CD25 regulatory T cells in de novo acute myeloid leukemia
por: Wan, Yuling, et al.
Publicado: (2020)

Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)‐T therapy has potential to reduce escape from single‐target CAR‐T with no more hematotoxicity
por: Wang, Zhenzhen, et al.
Publicado: (2023)

Author Correction: Repression of phagocytosis by human CD33 is not conserved with mouse CD33
por: Bhattacherjee, Abhishek, et al.
Publicado: (2020)

The clinical characteristics and prognosis in adult Ph negative acute lymphoblastic leukemia with TP53 aberrations
por: Fang, Qiuyun, et al.
Publicado: (2022)

The Assessment of CD56 and CD117 Expressions at the Time of the Diagnosis in Multiple Myeloma Patients
por: Ceran, Funda, et al.
Publicado: (2017)

Role of CD135/CD117 on Prognosis and Overall Survival of Acute Myeloid Leukemia
por: Raeisi, Mortaza, et al.
Publicado: (2019)

Immunoexpression of CD34, CD117, and p53 in Hypocellular Bone Marrow Disorders
por: Sharma, Pooja, et al.
Publicado: (2021)

CD117(+)CD44(+) Stem T Cells Develop in the Thymus and Potently Suppress T-cell Proliferation by Modulating the CTLA-4 Pathway
por: Wei, Yang, et al.
Publicado: (2017)

Neuroprotection of the hypoxic-ischemic mouse brain by human CD117(+)CD90(+)CD105(+) amniotic fluid stem cells
por: Corcelli, Michelangelo, et al.
Publicado: (2018)

CD33 splice site genotype was not associated with outcomes of patients receiving the anti-CD33 drug conjugate SGN-CD33A
por: Stanchina, Michele, et al.
Publicado: (2019)

Integration of CD34(+)CD117(dim) population signature improves the prognosis prediction of acute myeloid leukemia
por: Li, Xue-Ping, et al.
Publicado: (2022)

Relevance of TMPRSS2, CD163/CD206, and CD33 in clinical severity stratification of COVID-19
por: Martínez-Diz, Silvia, et al.
Publicado: (2023)

Extraordinarily elevated CD33 expression in CD56(+)CD3(–) cells in the bone marrow of a patient with relapsed acute myeloid leukemia: a case report
por: Wang, Dongyao, et al.
Publicado: (2021)

Formation of $^{117}In-H$ pairs after annealing of GaN implanted with $^{117}Cd(^{117}In)$
por: Dietrich, M, et al.
Publicado: (2001)

Redirection of CD4+ and CD8+ T lymphocytes via an anti-CD3 × anti-CD19 bi-specific antibody combined with cytosine arabinoside and the efficient lysis of patient-derived B-ALL cells
por: Fan, Dongmei, et al.
Publicado: (2015)

Inhibitory effects of metformin at low concentration on epithelial–mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells
por: Zhang, Rongrong, et al.
Publicado: (2015)

Extra-Thymic Physiological T Lineage Progenitor Activity Is Exclusively Confined to Cells Expressing either CD127, CD90, or High Levels of CD117
por: Saran, Namita, et al.
Publicado: (2012)

Downregulation of CD4+LAP+ and CD4+CD25+ Regulatory T Cells in Acute Coronary Syndromes
por: Lin, Ying-zhong, et al.
Publicado: (2013)

CD8+CD122+PD-1+ Tregs Synergize With Costimulatory Blockade of CD40/CD154, but Not B7/CD28, to Prolong Murine Allograft Survival
por: Liu, Huazhen, et al.
Publicado: (2019)

Responses of CD27(+)CD38(+) plasmablasts, and CD24(hi)CD27(hi) and CD24(hi)CD38(hi) regulatory B cells during primary dengue virus 2 infection
por: Lei, Chenshuang, et al.
Publicado: (2021)

Targeting the Membrane-Proximal C2-Set Domain of CD33 for Improved CD33-Directed Immunotherapy
por: Godwin, Colin D., et al.
Publicado: (2021)

Construction of CD19 targeted dual- and enhanced dual-antibodies and their efficiency in the treatment of B cell malignancy
por: Chen, Manling, et al.
Publicado: (2023)

Identification of Stem-Like Cells in Atrial Myxoma by Markers CD44, CD19, and CD45
por: Song, Xianghe, et al.
Publicado: (2016)

Detection of Cd(2+) in Aqueous Solution by the Fluorescent Probe of CdSe/CdS QDs Based on OFF–ON Mode
por: Wang, Dengpeng, et al.
Publicado: (2022)

Evaluation of the Expression of C-kit (CD117) in Ependymomas and Oligodendrogliomas
por: Zavalhia, Lisiane Silveira, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_hjahid8468hnvh0v44l6th70or